Cargando…
The POLD1(R689W) variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors
Inhibition of the kinase ATR, a central regulator of the DNA damage response, eliminates subsets of cancer cells in certain tumors. As previously shown, this is at least partly attributable to synthetic lethal interactions between ATR and POLD1, the catalytic subunit of the polymerase δ. Various POL...
Autores principales: | Job, Albert, Tatura, Marina, Schäfer, Cora, Lutz, Veronika, Schneider, Hanna, Lankat-Buttgereit, Brigitte, Zielinski, Alexandra, Borgmann, Kerstin, Bauer, Christian, Gress, Thomas M., Buchholz, Malte, Gallmeier, Eike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641191/ https://www.ncbi.nlm.nih.gov/pubmed/33144657 http://dx.doi.org/10.1038/s41598-020-76033-1 |
Ejemplares similares
-
Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors()
por: Job, Albert, et al.
Publicado: (2018) -
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
por: Hocke, Sandra, et al.
Publicado: (2016) -
Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
por: Liu, Kang, et al.
Publicado: (2021) -
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
por: Di Benedetto, Anna, et al.
Publicado: (2017) -
Targeting the ATR-CHK1 Axis in Cancer Therapy
por: Rundle, Stuart, et al.
Publicado: (2017)